Philips seen down after flagging delayed orders, pressure on D&T segment

Koninklijke Philips

28/07/2026 07:36

** Shares in Philips PHG.AS are seen down 3-5% after the company flagged delayed orders and market pressure on Diagnosis & Treatment (D&T) segment in Q2
** The Dutch healthcare technology company reports a 1% decline in order intake due to large orders shifting into Q3
** It also flagged market pressure in China weighing on D&T
** Traders say that while the company raised its outlook on tariff refunds, the focus would be on the decline in order growth and the soft margin performance in D&T
** RBC analysts also expect scrutiny on the order intake decline, "particularly given recent investor concerns around the US hospital capex environment"
** "While the reiteration of underlying FY guidance is encouraging, the H2 margin ramp implied by guidance looks to be more challenging," they add
** On Monday, U.S.-listed shares lost 4.4% to $25.02
     

(Reporting by Lucie Barbier in Gdansk)
((lucie.barbier@thomsonreuters.com))